Clinical Trials Directory

Trials / Unknown

UnknownNCT04658329

Cohorte Nationale VIH-2

Cohorte ANRS CO5 "Cohorte Nationale VIH2"

Status
Unknown
Phase
Study type
Observational
Enrollment
1,185 (estimated)
Sponsor
ANRS, Emerging Infectious Diseases · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The HIV2 study is an open cohort of prospective, multicentric, national observation. The main objective is to study HIV-2 infection in adult patients followed in France.

Detailed description

The secondary objectives are : * Describe the epidemiological and clinical characteristics of participants infected with HIV-2, and the immuno-virological characteristics of the infection. * To study the clinical and immunological progression of HIV-2 infection and the prognostic factors of this evolution. * Study the response to antiretroviral treatment (clinical, immuno-virological) and contribute to the identification of the antiretroviral strategies and combinations most suited to the particularities of the infection. * Allow an evaluation of the care practices of participants followed in French hospitals * Provide a bank of clinical-biological data and samples allowing the performance of virological and / or immunological studies on HIV-2 infection. The follow-up of the participants is different according to the therapeutic status of the participants, naive of antiretroviral treatment or already treated with antiretrovirals.

Conditions

Interventions

TypeNameDescription
DRUGAntiretroviralStudy the response to antiretroviral treatment (clinical, immuno-virological) and contribute to the identification of the antiretroviral strategies and combinations most suited to the particularities of the infection.

Timeline

Start date
1994-01-01
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2020-12-08
Last updated
2020-12-08

Locations

29 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04658329. Inclusion in this directory is not an endorsement.